You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SDF1-α

Showing 1 - 25 of 8,527
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atrial Fibrillation, Ischemic Heart Disease, CHF Trial in Hvidovre (DYNASDY)

Unknown status
  • Atrial Fibrillation
  • +2 more
  • DYNASDY
  • Hvidovre, Capital Region Of Denmark, Denmark
    Copenhagen University Hospital Hvidovre
Jul 13, 2020

Glucose Lowering Therapies on Circulating Endothelial Progenitor

Completed
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
    • Leicester, Leicestershire, United Kingdom
      Leicester Diabetes Centre
    Jan 29, 2020

    Transfusion-dependent a-Thalassemia Trial (GMCN-508A Drug Product)

    Not yet recruiting
    • Transfusion-dependent α-Thalassemia
    • GMCN-508A Drug Product
    • (no location specified)
    Feb 24, 2023

    Dentist's Role Trial in Cairo (SDF1, Diode Laser, Pit Fissure Sealant)

    Completed
    • Dentist's Role
    • Cairo, Egypt
      Faculty of Dentistry British University
    Nov 5, 2023

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • [212Pb] VMT-α-NET
    • [203Pb] VMT-α-NET SPECT/CT
    • Iowa City, Iowa
      Holden Comprehensive Cancer Center at the University of Iowa
    Nov 30, 2023

    GCF PLAP-1, Sclerostin and TNF-a Levels in Periodontitis

    Completed
    • Periodontitis
    • Periodontal clinical measurements and GCF sampling
    • Aydın, Turkey
      Adnan Menderes University, Faculty of Dentistry, Department of P
    Dec 8, 2022

    Sublingual Microcirculation in Compensated T1D Using SDF Method

    Recruiting
    • Type1diabetes
      • Ústí Nad Labem, Czechia
        Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
      Jul 14, 2023

      Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)

      Enrolling by invitation
      • Neuroendocrine Tumor Grade 2
      • Neuroendocrine Tumor Grade 1
      • Iowa City, Iowa
        The University of Iowa
      Dec 9, 2022

      EVALUATION OF MACROPHAGE INFLAMMATORY PROTEIN-1a AS A

      Not yet recruiting
      • Periodontitis Chronic Generalized Severe
      • +2 more
        • Rohtak, Haryana, India
          Post Graduate Institute of Dental Sciences
        Aug 23, 2023

        Melanoma Trial in Xi'an (Recombinant human interferon a1b, Toripalimab, Anlotinib HCl)

        Not yet recruiting
        • Melanoma
        • Recombinant human interferon α1b
        • +2 more
        • Xi'an, Shaanxi, China
          Air Force Military Medical University/ Fourth Military Medical U
        Sep 13, 2022

        Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

        Recruiting
        • Fanconi Anemia
        • +2 more
        • Total Body Irradiation (TBI) (Plan 1)
        • +8 more
        • Minneapolis, Minnesota
          Masonic Cancer Center at University of Minnesota
        Nov 2, 2022

        Periodontitis Trial in Rize (biochemical analysis)

        Completed
        • Periodontitis
        • biochemical analysis
        • Rize, Turkey
          Recep Tayyip Erdogan University
        Oct 18, 2023

        Intercellular Adhesion Molecule-1 and TNF-a in COVID-19

        Completed
        • COVID-19
        • Cytokine Storm
          • Banhā, Kalyobia, Egypt
            Benha University hospital
          Jun 10, 2022

          Periodontal Diseases Trial in Izmir (saliva obtaining)

          Active, not recruiting
          • Periodontal Diseases
          • saliva obtaining
          • İzmir, Çiğli, Turkey
            Izmir Katip Çelebi University Department of Periodontology
          Mar 21, 2023

          Herpes Zoster Trial (Peginterferon a1b, Peginterferon a1b with valacyclovir, Valacyclovir)

          Not yet recruiting
          • Herpes Zoster
          • Peginterferon α1b
          • +2 more
          • (no location specified)
          Aug 5, 2022

          Molar Incisor Hypomineralization, Anesthesia, Local Trial in Ann Arbor (SDF, Placebo)

          Recruiting
          • Molar Incisor Hypomineralization
          • Anesthesia, Local
          • SDF
          • Placebo
          • Ann Arbor, Michigan
            University of Michigan
          Jul 18, 2023

          NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

          Recruiting
          • Non-small Cell Lung Cancer
          • Hypofractionated radiotherapy
          • +4 more
          • Guangzhou, Guangdong, China
            Sun yat-sen university cancer center
          Nov 14, 2023

          Rheumatic Heart Disease, Cardiopulmonary Bypass, Immunotherapy Trial in Nanjing (Thymosin Alpha1, Blank Control)

          Recruiting
          • Rheumatic Heart Disease
          • +2 more
          • Thymosin Alpha1
          • Blank Control
          • Nanjing, Jiangsu, China
            The first affiliated hospital of nanjing medical university
          Aug 3, 2022

          ER+ Breast Cancer Trial in Sherbrooke (4FMFES-PET)

          Recruiting
          • ER+ Breast Cancer
          • 4FMFES-PET
          • Sherbrooke, Quebec, Canada
            Université deSherbrooke
          Jul 18, 2022

          Root Caries Trial (S-PRG barrier coat)

          Not yet recruiting
          • Root Caries
          • S-PRG barrier coat
          • (no location specified)
          Aug 19, 2022

          Alpha -1- Microglobulin asEarly Biomarker in Renal Extrahepatic

          Not yet recruiting
          • Renal Injury
          • HCV
            • (no location specified)
            May 3, 2022

            Pyoderma, Pyoderma Gangrenosum, Pyoderma Vegetans Trial in Minsk, Riga (Monoclonal antibody (Mab) sB24M)

            Active, not recruiting
            • Pyoderma
            • +3 more
            • Monoclonal antibody (Mab) sB24M
            • Minsk, Belarus
            • +1 more
            Jul 8, 2022

            Acute Aortic Syndrome, Aortic Dissectio Trial in Nanjing, Beijing (Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic

            Recruiting
            • Acute Aortic Syndrome
            • Aortic Dissectio
            • Thymosin Alpha1, 28A-Glycine-28B-L-Arginine-28C-L-Glutamic Acid-28D-L-Alanine-28E-L-Proline-28F-L-Alanine-28G-L-Asparagine-
            • Blank control
            • Nanjing, Jiangsu, China
            • +2 more
            Sep 25, 2022

            Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

            Not yet recruiting
            • Sickle Cell Disease
            • Saint Louis, Missouri
              Washington University School of Medicine
            Nov 8, 2022

            Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A

            Not yet recruiting
            • Hif-1α Covid-19
            • HiF-1 alpha measurement
            • (no location specified)
            Dec 14, 2021